7 min read
Monthly FDA Guidance and Regulatory News Review - April 2026
This April 2026 regulatory update highlights new policies on biomarker validation, expanded access to investigational...
1 min read
Meet Veristat in Barcelona at BIOSPAIN 2023, 26-28 September 2023
With more than 29 years of experience in clinical trial planning and execution, Veristat is equipped to support any development program.
As you look to transition your compound into clinical trials, you need the right partner to guide your planning and decision-making. Whether you are preparing your IND/CTA, or you are looking to recruit patients quickly to get your early phase trials running, or just need medical writing or biostatistical support for your programs – Veristat can help.
We provide impactful solutions on both a full-service or functional service basis, including strategic regulatory guidance, clinical program design, and IND/CTA support through to successful regulatory approval.
Veristat’s Presenter at BIOSPAIN 2023:
Montse Barceló Riera,M.D.
We are pleased to announce that Montse Barceló Riera M.D., Vice President of Europe at Veristat, will be a speaker at the plenary session, The Patient Voice as a Starting and Ending Point for the Development of New Innovative Healthcare Solutions.
Panel Summary:
New science, new technologies, new challenges, and constant change are impacting the way we discover, develop, and provide new healthcare solutions to those suffering from a disease. The complexity of this constellation of innovation can easily eclipse the efforts being made. As sponsors move forward with their development strategies, the voice of the patient can play an essential role in establishing relevant new drug development objectives amidst the complexity. Patient perspectives and expectations can make significant contributions to what is needed for designing, investigating, and providing solutions that address their real-world challenges.
Panelists will also discuss the latest digital technologies in healthcare, bringing in perspectives from clinical experts and pharmaceutical sponsors as they debate how digital technology innovation could benefit from patient insights.
Panel Date: 27th September, 11:30 to 12:15 CET
Moderator:
Jose Maria Gimenez Arnau, Chief Scientific & Medical Officer, ESTEVE Healthcare
Speakers:
Fulvio Capitanio, member of the World Parkinson Coalition 2023 Steering Committee, Barcelona
Carmen Rios Benton, Founder Doctomatic. Member Board Tech Barcelona
Begoña Nafría Escalera, Patient engagement & Research coordinator, Hospital Sant Joan de Déu, Barcelona. Coordinator eYPAGnet
Montse Barceló Riera, VP Europe Veristat
Schedule A Meeting with US:
Veristat team members, Montse Barceló Riera MD, VP Europe, and Balma Gil, Business Development, will be at the venue, ready to listen to your needs and share Veristat’s expertise.
If you would like to meet us at BIOSPAIN 2023, feel free to contact us to arrange a meeting through the form.
Conference Details
Website: BIOSPAIN 2023